Apimeds Pharmaceuticals Us, Inc. · AMEX:APUS

Apimeds Pharmaceuticals Us, Inc. shareholders

As of Jun 30, 2026, 6 institutions reported holding Apimeds Pharmaceuticals Us, Inc., 2.8% of its shares. Largest: Hemenway Trust Co LLC, Vanguard and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Apimeds Pharmaceuticals Us, Inc.ChangeFiled
Hemenway Trust Co LLC274K1.8%no changeAug 11, 2026
Vanguard87,6930.58%−32,275Aug 13, 2026
Geode Capital35,1140.23%−4,937Aug 12, 2026
Jane Street15,9930.11%newAug 14, 2026
UBS11,8180.08%+7,631Aug 13, 2026
Tower Research Capital LLC (TRC)1,6640.01%newAug 11, 2026

Apimeds Pharmaceuticals Us, Inc. insider trades